Tetricus Labs Company Profile

Background

Founded in 2022, Tetricus Labs is a precision psychiatry company headquartered in New Haven, Connecticut. The company aims to revolutionize the patient journey from diagnosis to treatment and recovery by integrating advancements in neuroscience and machine learning. Tetricus Labs develops software solutions for psychiatric hospitals and independent providers, enabling comprehensive assessment of patient data to personalize and optimize mental health care.

Key Strategic Focus

Tetricus Labs focuses on enhancing the precision of mental health diagnoses and treatments through its machine learning platform. The platform facilitates the collection and analysis of a patient's digital phenotype, assisting clinicians in tracking progress and tailoring treatments over time. By providing tools for comprehensive patient assessment, treatment matching, and outcome monitoring, Tetricus Labs aims to improve patient outcomes and streamline psychiatric care delivery.

Financials and Funding

In September 2023, Tetricus Labs secured a seed investment from Research Bridge Partners, a venture capital firm specializing in biomedical startups. The funding is intended to support the development of the company's leadership team and clinical trials for its machine learning platform. As part of the investment, Isaac Barchas, Co-Founder and CEO of Research Bridge Partners, joined Tetricus Labs' board of directors.

Pipeline Development

Tetricus Labs is developing Sigmund.AI, a machine learning-based patient evaluation tool designed to assess diagnosis and acuity for patient triage and remote monitoring in hospital and clinical trial settings. The company has partnered with Silver Hill Hospital on a two-year feasibility study to evaluate how machine learning can improve patient outcomes in precision psychiatry.

Technological Platform and Innovation

Tetricus Labs' platform leverages machine learning to create personalized patient profiles, predicting responses to interventions for complex mental illnesses. This multi-modal data approach enables comprehensive assessment of new referrals, appropriate treatment matching, and continuous outcome monitoring to refine care over time.

Leadership Team

Lindsay Dow, Co-Founder and Chief Executive Officer

Former healthcare investment banker at Evercore Partners and mental health advocate.

Dr. Philip Corlett, Co-Founder and Scientific Founder

Associate Professor of Psychiatry and Psychology at Yale University, expert in computational neuroscience.

Dr. Sean McCurdy, Co-Founder and Chief Scientific Officer

Former Head of Ad Solutions Data Science at Pinterest.

Nikk Wong, Chief Technology Officer

Richard Winslow, Ph.D., Chief Technology Officer

Leadership Changes

In September 2023, Isaac Barchas, Co-Founder and CEO of Research Bridge Partners, joined Tetricus Labs' board of directors following the firm's seed investment in the company.

Competitor Profile

Market Insights and Dynamics

The precision psychiatry market is experiencing growth due to increasing demand for personalized mental health treatments and advancements in machine learning applications. The integration of AI in mental health care aims to address challenges such as misdiagnosis rates and treatment resistance among patients.

Competitor Analysis

Clarigent Health: Develops AI-powered tools for mental health assessments, focusing on vocal biomarkers to assist clinicians in evaluating patient risk levels.

Amae Health: Specializes in treating severe mental illnesses through a value-based, psychiatry-led model, emphasizing comprehensive care.

Slingshot AI: Focuses on leveraging artificial intelligence to enhance mental health care, aiming to improve human decision-making in clinical settings.

Author Health: Provides a platform offering comprehensive care and treatment for Medicare Advantage recipients with serious mental illnesses and substance use disorders.

These competitors are also integrating AI and machine learning to improve mental health diagnostics and treatment personalization.

Strategic Collaborations and Partnerships

Tetricus Labs has partnered with Silver Hill Hospital, a leading psychiatric hospital, on a two-year feasibility study to assess the impact of machine learning on patient outcomes in precision psychiatry. Additionally, the company was accepted into the One Mind Accelerator program, receiving funding and support to advance its digital platform for mental health treatment evaluation and monitoring.

Operational Insights

Tetricus Labs differentiates itself by combining patient-centered approaches with advanced machine learning techniques to enhance diagnostic precision and treatment efficacy in psychiatry. The company's collaborations with esteemed institutions and participation in accelerator programs position it to address challenges in mental health care delivery effectively.

Strategic Opportunities and Future Directions

Tetricus Labs aims to expand its platform's capabilities, incorporating additional data modalities and refining its machine learning algorithms to improve predictive accuracy. The company plans to establish further partnerships with psychiatric institutions and healthcare providers to broaden the adoption of its technology, ultimately enhancing patient outcomes on a larger scale.